Publication:
ERC-funded proof of concept grant: targeting imidazoline 1-receptor in atherosclerosis.

dc.contributor.authorMastrangelo, Annalaura
dc.contributor.authorRobles-Vera, Iñaki
dc.contributor.authorSancho, David
dc.date.accessioned2026-03-20T10:33:34Z
dc.date.available2026-03-20T10:33:34Z
dc.date.issued2026-03-09
dc.description.peerreviewed
dc.description.tableofcontentsWork in the D.S. laboratory is funded by the Centro Nacional de Investigaciones Cardiovasculares (CNIC); the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement ERC-2016-Consolidator Grant 725091; Ministerio de Ciencia, Innovación y Universidades PID2022-137712OB-I00, CPP2021-0083 10, CPP2022-009762 and CPP2024-011365 MICIU/AEI/10.13039/501100011033 Agencia Estatal de Investigación, Unión Europea NextGenerationEU/PRTR; Comunidad de Madrid (P2022/BMD-7333 INMUNOVAR-CM); Scientific Foundation of the Spanish Association Against Cancer (AECC-PRYGN246642SANC); Worldwide Cancer Research WWCR-25-0080; European Union ERC-2023-PoC; a research agreement with Inmunotek Ltd; and la Caixa Foundation (LCF/PR/HR23/52430012 and LCF/PR/HR22/52420019). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MICIU and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence funded by Ministerio de Ciencia, Innovación y Universidades (CEX2020-001041-S funded by MICIU/AEI/10.13039/501100011033). The PESA study is funded by the CNIC and Banco Santander. This study was partially funded by an intramural grant to Borja Ibáñez and D.S.
dc.format.number10
dc.format.page1141-1143
dc.format.volume47
dc.identifier.citationEur Heart J. 2026 Mar 9;47(10):1141-1143
dc.identifier.journalEUROPEAN HEART JOURNAL
dc.identifier.pubmedID41528840
dc.identifier.urihttps://hdl.handle.net/20.500.12105/27340
dc.language.isoeng
dc.publisherOXFORD UNIV PRESS
dc.relation.isreferencedbyPubMed
dc.relation.publisherversion10.1093/eurheartj/ehaf1122
dc.repisalud.institucionCNIC
dc.repisalud.orgCNICCNIC::Grupos de investigación::Inmunobiología
dc.rights.accessRightsopen access
dc.titleERC-funded proof of concept grant: targeting imidazoline 1-receptor in atherosclerosis.
dc.typeeditorial
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ERC_funded proof of concept grant_Eur Heart J_2026.pdf
Size:
171.72 KB
Format:
Adobe Portable Document Format